Bachem Holding AG (SWX:BANB)

Market Cap	4.42B
Revenue (ttm)	577.77M
Net Income (ttm)	113.57M
Shares Out	74.97M
EPS (ttm)	1.52
PE Ratio	38.88
Forward PE	35.06
Dividend	0.80 (1.38%)
Ex-Dividend Date	Apr 26, 2024

Volume	124,308
Average Volume	114,415
Open	58.00
Previous Close	58.05
Day's Range	58.00 - 59.40
52-Week Range	54.70 - 91.65
Beta	0.75
RSI	55.76
Earnings Date	Feb 27, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,006
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2023, Bachem Holding AG's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.